Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.
Observational · No treatment assigned · 1 site · Asan Medical Center
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Crohn's Disease, Ulcerative Colitis and Epidemiology. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Age range not stated in the record
- Any sex
Some of the main requirements, copied from the record:
- Definite cases of CD and UC
- Patients are diagnosed with CD if they meet at least 2 of the following criteria:
- clinical history of abdominal pain, weight loss, malaise, diarrhea, and/or rectal bleeding
Plus 9 more requirement(s). There are also 2 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 2000 participants are expected to take part.
- Start date: 2012-12.
- Main results expected around 2029-06 (estimate from the record).
- 1 study site listed (1 marked recruiting) in South Korea.
Main thing being measured
- Incidence rate and prevalence rate of IBD (1986-2017 (up to 31 years))
In the researchers’ words
The purpose of this study is to evaluate the incidence, prevalence, clinical characteristics and prognosis of Crohn's disease and ulcerative colitis over time in a district of Seoul, Korea.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Crohn's Disease; Ulcerative Colitis; Epidemiology; Korea |
| Lead sponsor | Asan Medical Center |
| Collaborators | Kyung Hee University Hospital at Gangdong; Seoul National University Hospital; Seoul National University Bundang Hospital; Samsung Medical Center; Konkuk University Medical Center; National Police Hospital; Seoul Veterans Hospital; hansol hospital; Kangdong Seoul Clinic; Jamsil Seoul Surgical Clinic; Song Do Colorectal Hospital; Yang Hospital; Daehang Hospital; Kangdong Sacred Heart Hospital |
| Enrollment | 2000 (estimated) |
| Start date | 2012-12 |
| Primary completion (est.) | 2029-06 |
| First posted | 2012-11-22 |
| Last updated | 2021-01-13 |
| Official title | Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea. |
| ClinicalTrials.gov ID | NCT01731665 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Definite cases of CD and UC Patients are diagnosed with CD if they meet at least 2 of the following criteria: 1. clinical history of abdominal pain, weight loss, malaise, diarrhea, and/or rectal bleeding 2. endoscopic findings of mucosal cobblestoning, linear ulceration, skip areas, or perianal disease 3. radiologic findings of stricture, fistula, mucosal cobblestoning, or ulceration 4. macroscopic appearance of bowel wall induration, mesenteric lymphadenopathy, and "creeping fat" at laparotomy 5. pathologic findings of transmural inflammation and/or epithelioid granulomas Only patients who meet these criteria for at least 2 months are included. Patients are diagnosed with UC only if all 3 of the following criteria are present 1. a typical history of diarrhea or blood and pus or both in the stool for longer than 4 weeks 2. a typical sigmoidoscopic or colonoscopic picture with diffusely granular, friable, or ulcerated mucosa without rectal sparing or skip lesions or radiological signs of characteristic continuous granular or ulcerated mucosa 3. characteristic histopathological signs of inflammation on biopsy Exclusion Criteria: * IBD unclassified * Ethnic groups other than Korean
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.